These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12062908)

  • 1. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.
    Ginovart N; Hassoun W; Le Cavorsin M; Veyre L; Le Bars D; Leviel V
    Neuropsychopharmacology; 2002 Jul; 27(1):72-84. PubMed ID: 12062908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique.
    Sasaki T; Ishiwata K; Murata T; Senda M
    Synapse; 2002 Apr; 44(1):42-50. PubMed ID: 11842445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.
    Marenco S; Carson RE; Berman KF; Herscovitch P; Weinberger DR
    Neuropsychopharmacology; 2004 Feb; 29(2):259-68. PubMed ID: 14666115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
    Kobayashi K; Inoue O; Watanabe Y; Onoe H; Långström B
    J Neural Transm Gen Sect; 1995; 100(2):147-51. PubMed ID: 8962684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats.
    Kilbourn MR; Domino EF
    Eur J Pharmacol; 2011 Mar; 654(3):254-7. PubMed ID: 21262223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia.
    Adler CM; Malhotra AK; Elman I; Pickar D; Breier A
    Neuropsychopharmacology; 2002 Mar; 26(3):295-300. PubMed ID: 11850144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data.
    Mauger G; Saba W; Hantraye P; Dolle F; Coulon C; Bramoullé Y; Chalon S; Grégoire MC
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1517-27. PubMed ID: 15917750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
    Seeman P; Tallerico T; Ko F; Tenn C; Kapur S
    Synapse; 2002 Dec; 46(4):235-9. PubMed ID: 12373738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Wong C; Ma J; Pradhan K; Tomasi D; Thanos PK; Ferré S; Jayne M
    J Neurosci; 2008 Aug; 28(34):8454-61. PubMed ID: 18716203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.